奥地利科学研究院癌症免疫疗法博士后职位
The research group of Robert Kralovics at CeMM, the Research Center for Molecular Medicine of the Austrian Academy of Sciences in Vienna is looking for highly motivated individuals with experience in the fields of cancer immunotherapy and/or antibody engineering. The group has recently identified novel mutations in the gene CALR in MPN patients. The objective of the project is to develop new therapeutic strategies for CALR-positive MPN (Klampfl et. al., N Engl J Med 369(25):2379-90, 2013).
Requirements and desired qualifications:
- PhD in immunology, molecular biology or biochemistry
- high accuracy and reliability
- excellent interpersonal skills and ability to work in an
- international team
- very good/excellent written and oral communication skills in English
- previous experience with antibody production or engineering, vaccine development, mouse models, cancer immunotherapy are preferred
Deadline for Applications: 15 March 2014
CeMM is the novel, international, independent and interdisciplinary Research Center for Molecular Medicine of the Austrian Academy of Sciences committed to advancing the understanding of human diseases through basic and biomedical research. Located in a tailor-made building in the midst of the campus of the Medical University of Vienna, CeMM is dedicated to its mission statement “from the clinic to the clinic” and fosters a highly collaborative and interactive research mindset. The official language at CeMM is English.
声明：凡本网注明"来源：XXX"的文/图等稿件，本网转载出于传递更多信息及方便产业探讨之目的，并不意味着本站赞同其观点或证实其内容的真实性，文章内容仅供参考。如其他媒体、网站或个人从本网站转载使用，须保留本网站注明的“来源”，并自负版权等法律责任。作者如果不希望被转载或者联系转载等事宜，请与我们联系。
